Literature DB >> 1713939

The current status of targeting tumour vasculature as a means of cancer therapy: an overview.

J Denekamp1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1713939     DOI： 10.1080/09553009114552251

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN： 0955-3002            Impact factor:   2.694


× No keyword cloud information.
  9 in total

1.  Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model.

Authors:  F Griscelli; H Li; C Cheong; P Opolon; A Bennaceur-Griscelli; G Vassal; J Soria; C Soria; H Lu; M Perricaudet; P Yeh
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

Review 2.  QTc prolongation induced by targeted biotherapies used in clinical practice and under investigation: a comprehensive review.

Authors:  Marzia Locatelli; Carmen Criscitiello; Angela Esposito; Ida Minchella; Aron Goldhirsch; Carlo Cipolla; Giuseppe Curigliano
Journal:  Target Oncol       Date:  2014-06-27       Impact factor: 4.493

Review 3.  Matrix metalloproteinase inhibitors.

Authors:  S M Wojtowicz-Praga; R B Dickson; M J Hawkins
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

4.  Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxel.

Authors:  Michael Millward; Paul Mainwaring; Alain Mita; Kristine Federico; G K Lloyd; Natasha Reddinger; Steffan Nawrocki; Monica Mita; Matthew A Spear
Journal:  Invest New Drugs       Date:  2011-02-16       Impact factor: 3.850

5.  Isolation of endothelial progenitor cells from cord blood and induction of differentiation by ex vivo expansion.

Authors:  Jeong-Won Shin; Dong-Wha Lee; Moon-Jung Kim; Kyung-Soon Song; Han-Soo Kim; Hyun-Ok Kim
Journal:  Yonsei Med J       Date:  2005-04-30       Impact factor: 2.759

Review 6.  Growth factor targeted and conventional therapy of breast cancer.

Authors:  A Wellstein
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

7.  Abemaciclib, a Selective CDK4/6 Inhibitor, Enhances the Radiosensitivity of Non-Small Cell Lung Cancer In Vitro and In Vivo.

Authors:  Sarwat Naz; Anastasia Sowers; Rajani Choudhuri; Maria Wissler; Janet Gamson; Askale Mathias; John A Cook; James B Mitchell
Journal:  Clin Cancer Res       Date:  2018-05-01       Impact factor: 12.531

8.  Effects of radiotherapy and estramustine on the microvasculature in malignant glioma.

Authors:  M Johansson; A T Bergenheim; A Widmark; R Henriksson
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

9.  Combined effects of an angiogenesis inhibitor (TNP-470) and hyperthermia.

Authors:  Y Nishimura; R Murata; M Hiraoka
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.